Shareholder alert: weiss law investigates forma therapeutics holdings, inc.

New york , sept. 1, 2022 /prnewswire/ -- weiss law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of forma therapeutics holdings, inc. ("forma therapeutics" or the "company") (nasdaq: fmtx), in connection with the proposed acquisition of the company by novo nordisk a/s (nyse: nvo) via tender offer.

NVO Ratings Summary

NVO Quant Ranking